Endocrinology Research Centre, Moscow 117292, Russia.
Int J Mol Sci. 2024 Nov 8;25(22):11998. doi: 10.3390/ijms252211998.
GATA6 syndrome is a rare monogenic disorder caused by heterozygous variants in the gene , which controls the early embryonic differentiation of germ layers and the development of different organs. We present the results of the 7-year follow-up of a child with this syndrome as well as the following conditions: diabetes mellitus, exocrine pancreatic insufficiency, gallbladder atresia, and congenital heart disease (CHD). At birth, the patient was diagnosed with neonatal diabetes mellitus (NDM) associated with heart (mitral valve prolapse) and gastrointestinal abnormalities (gallbladder atresia). Diabetes remitted within weeks and relapsed at the age of 2. We identified a de novo variant of a 4-nucleotide deletion (c.1302+4_1302+7del), previously unreported in the literature, in the donor splicing site of exon 3 of the gene in a heterozygous state. Screening for other possible components of GATA6 syndrome revealed exocrine pancreatic insufficiency, and pancreatic enzyme replacement therapy resulted in improved dyspeptic symptoms, and growth rates increased. In addition, the patient was diagnosed with autoimmune thyroiditis and progressive myopia.
GATA6 综合征是一种罕见的单基因疾病,由基因中的杂合变异引起,该基因控制着胚胎早期的胚层分化和不同器官的发育。我们报告了一名患有这种综合征的儿童 7 年的随访结果,以及以下情况:糖尿病、外分泌胰腺功能不全、胆囊闭锁和先天性心脏病(CHD)。患儿出生时被诊断为与心脏(二尖瓣脱垂)和胃肠道异常(胆囊闭锁)相关的新生儿糖尿病(NDM)。数周内糖尿病缓解,但在 2 岁时复发。我们在基因的外显子 3 的供体位点发现了一个 4 个核苷酸缺失(c.1302+4_1302+7del)的从头变异,该变异之前在文献中未报道过,为杂合状态。对 GATA6 综合征的其他可能成分进行筛查发现外分泌胰腺功能不全,胰腺酶替代治疗改善了消化不良症状,生长速度也有所提高。此外,该患者还被诊断为自身免疫性甲状腺炎和进行性近视。